Table of Contents

1 Study Coverage

• 1.1 Anakinra Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Anakinra Market Size Growth Rate by Product
  • 1.4.2 10MIU/VIAL
  • 1.4.3 18MIU/VIAL
  • 1.4.4 25MIU/VIAL
• 1.5 Market by End User
  • 1.5.1 Global Anakinra Market Size Growth Rate by End User
  • 1.5.2 Pediatrics
  • 1.5.3 Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Anakinra Market Size
  • 2.1.1 Global Anakinra Revenue 2014-2025
  • 2.1.2 Global Anakinra Sales 2014-2025
• 2.2 Anakinra Growth Rate by Regions
  • 2.2.1 Global Anakinra Sales by Regions
  • 2.2.2 Global Anakinra Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Anakinra Sales by Manufacturers
  • 3.1.1 Anakinra Sales by Manufacturers
  • 3.1.2 Anakinra Sales Market Share by Manufacturers
  • 3.1.3 Global Anakinra Market Concentration Ratio (CR5 and HHI)
• 3.2 Anakinra Revenue by Manufacturers
  • 3.2.1 Anakinra Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anakinra Revenue Share by Manufacturers (2014-2019)
• 3.3 Anakinra Price by Manufacturers
• 3.4 Anakinra Manufacturing Base Distribution, Product Types
  • 3.4.1 Anakinra Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Anakinra Product Type
  • 3.4.3 Date of International Manufacturers Enter into Anakinra Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Anakinra Sales by Product
• 4.2 Global Anakinra Revenue by Product
• 4.3 Anakinra Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Anakinra Breakdown Data by End User

6 North America

• 6.1 North America Anakinra by Countries
  • 6.1.1 North America Anakinra Sales by Countries
  • 6.1.2 North America Anakinra Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Anakinra by Product
• 6.3 North America Anakinra by End User

7 Europe

• 7.1 Europe Anakinra by Countries
  • 7.1.1 Europe Anakinra Sales by Countries
  • 7.1.2 Europe Anakinra Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Anakinra by Product
• 7.3 Europe Anakinra by End User

8 Asia Pacific

• 8.1 Asia Pacific Anakinra by Countries
  • 8.1.1 Asia Pacific Anakinra Sales by Countries
  • 8.1.2 Asia Pacific Anakinra Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Anakinra by Product
• 8.3 Asia Pacific Anakinra by End User

9 Central & South America

• 9.1 Central & South America Anakinra by Countries
  • 9.1.1 Central & South America Anakinra Sales by Countries
  • 9.1.2 Central & South America Anakinra Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Anakinra by Product
• 9.3 Central & South America Anakinra by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Anakinra by Countries
  • 10.1.1 Middle East and Africa Anakinra Sales by Countries
  • 10.1.2 Middle East and Africa Anakinra Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Anakinra by Product
• 10.3 Middle East and Africa Anakinra by End User

11 Company Profiles

• 11.1 Swedish Orphan Biovitrum
  • 11.1.1 Swedish Orphan Biovitrum Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Swedish Orphan Biovitrum Anakinra Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Swedish Orphan Biovitrum Anakinra Products Offered
  • 11.1.5 Swedish Orphan Biovitrum Recent Development

12 Future Forecast

• 12.1 Anakinra Market Forecast by Regions
  • 12.1.1 Global Anakinra Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Anakinra Revenue Forecast by Regions 2019-2025
• 12.2 Anakinra Market Forecast by Product
  • 12.2.1 Global Anakinra Sales Forecast by Product 2019-2025
  • 12.2.2 Global Anakinra Revenue Forecast by Product 2019-2025
• 12.3 Anakinra Market Forecast by End User
• 12.4 North America Anakinra Forecast
• 12.5 Europe Anakinra Forecast
• 12.6 Asia Pacific Anakinra Forecast
• 12.7 Central & South America Anakinra Forecast
• 12.8 Middle East and Africa Anakinra Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Anakinra Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Anakinra (brand name Kineret) is a biopharmaceutical drug used to treat rheumatoid arthritis. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan
The global Anakinra market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anakinra market based on company, product type, end user and key regions.

This report studies the global market size of Anakinra in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anakinra in these regions.
This research report categorizes the global Anakinra market by top players/brands, region, type and end user. This report also studies the global Anakinra market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Swedish Orphan Biovitrum

Market size by Product
10MIU/VIAL
18MIU/VIAL
25MIU/VIAL
Market size by End User
Pediatrics
Adults

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anakinra market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anakinra market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anakinra companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anakinra submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anakinra are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anakinra market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.